Basic Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 105311
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.105311
Figure 1
Figure 1 Differences in tumor marker levels among sample types. A-F: Differences in tumor markers in blood, bile, and feces of patients with hepatocellular carcinoma (HCC) and non-HCC; G and H: Comparative analysis of alpha-fetoprotein (AFP) and prothrombin induced by vitamin K absence-II (PIVKA-II) levels in blood and bile among patients with HCC.